Antibody mediated activation of natural killer cells in malaria exposed pregnant women
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Antibody mediated activation of natural killer cells in malaria exposed pregnant women. / Damelang, Timon; Aitken, Elizabeth H; Hasang, Wina; Lopez, Ester; Killian, Martin; Unger, Holger W; Salanti, Ali; Shub, Alexis; McCarthy, Elizabeth; Kedzierska, Katherine; Lappas, Martha; Kent, Stephen J; Rogerson, Stephen J; Chung, Amy W.
In: Scientific Reports, Vol. 11, 4130, 2021.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Antibody mediated activation of natural killer cells in malaria exposed pregnant women
AU - Damelang, Timon
AU - Aitken, Elizabeth H
AU - Hasang, Wina
AU - Lopez, Ester
AU - Killian, Martin
AU - Unger, Holger W
AU - Salanti, Ali
AU - Shub, Alexis
AU - McCarthy, Elizabeth
AU - Kedzierska, Katherine
AU - Lappas, Martha
AU - Kent, Stephen J
AU - Rogerson, Stephen J
AU - Chung, Amy W
PY - 2021
Y1 - 2021
N2 - Immune effector responses against Plasmodium falciparum include antibody-mediated activation of innate immune cells, which can induce Fc effector functions, including antibody-dependent cellular cytotoxicity, and the secretion of cytokines and chemokines. These effector functions are regulated by the composition of immunoglobulin G (IgG) Fc N-linked glycans. However, a role for antibody-mediated natural killer (NK) cells activation or Fc N-linked glycans in pregnant women with malaria has not yet been established. Herein, we studied the capacity of IgG antibodies from pregnant women, with placental malaria or non-placental malaria, to induce NK cell activation in response to placental malaria-associated antigens DBL2 and DBL3. Antibody-mediated NK cell activation was observed in pregnant women with malaria, but no differences were associated with susceptibility to placental malaria. Elevated anti-inflammatory glycosylation patterns of IgG antibodies were observed in pregnant women with or without malaria infection, which were not seen in healthy non-pregnant controls. This suggests that pregnancy-associated anti-inflammatory Fc N-linked glycans may dampen the antibody-mediated activation of NK cells in pregnant women with malaria infection. Overall, although anti-inflammatory glycans and antibody-dependent NK cell activation were detected in pregnant women with malaria, a definitive role for these antibody features in protecting against placental malaria remains to be proven.
AB - Immune effector responses against Plasmodium falciparum include antibody-mediated activation of innate immune cells, which can induce Fc effector functions, including antibody-dependent cellular cytotoxicity, and the secretion of cytokines and chemokines. These effector functions are regulated by the composition of immunoglobulin G (IgG) Fc N-linked glycans. However, a role for antibody-mediated natural killer (NK) cells activation or Fc N-linked glycans in pregnant women with malaria has not yet been established. Herein, we studied the capacity of IgG antibodies from pregnant women, with placental malaria or non-placental malaria, to induce NK cell activation in response to placental malaria-associated antigens DBL2 and DBL3. Antibody-mediated NK cell activation was observed in pregnant women with malaria, but no differences were associated with susceptibility to placental malaria. Elevated anti-inflammatory glycosylation patterns of IgG antibodies were observed in pregnant women with or without malaria infection, which were not seen in healthy non-pregnant controls. This suggests that pregnancy-associated anti-inflammatory Fc N-linked glycans may dampen the antibody-mediated activation of NK cells in pregnant women with malaria infection. Overall, although anti-inflammatory glycans and antibody-dependent NK cell activation were detected in pregnant women with malaria, a definitive role for these antibody features in protecting against placental malaria remains to be proven.
U2 - 10.1038/s41598-021-83093-4
DO - 10.1038/s41598-021-83093-4
M3 - Journal article
C2 - 33602987
VL - 11
JO - Scientific Reports
JF - Scientific Reports
SN - 2045-2322
M1 - 4130
ER -
ID: 257138435